Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1995-4-3
|
| pubmed:language |
rus
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0372-9311
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
46-8
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:7879532-Adjuvants, Immunologic,
pubmed-meshheading:7879532-Drug Therapy, Combination,
pubmed-meshheading:7879532-Humans,
pubmed-meshheading:7879532-Immunity, Innate,
pubmed-meshheading:7879532-Occupational Health,
pubmed-meshheading:7879532-Russia,
pubmed-meshheading:7879532-Trace Elements,
pubmed-meshheading:7879532-Vitamins
|
| pubmed:articleTitle |
[Validation of the choice of the optimal immunopharmacological schemes for performing mass antigen-nonspecific immunoprophylactic measures].
|
| pubmed:publicationType |
Journal Article
|